One-Year Real-World Outcomes of Intravitreal Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration in Japan: A Multicenter Retrospective Study

Rikuto Mizuma, Yuki Mizuki, Akihiro Kamata, Junji Onishi, Takuto Sakono, Misa Suzuki, Nobuhisa Mizuki

Open source

DOI
10.2147/opth.s596218
Published
2026-03
Container
Clinical Ophthalmology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/opth.s596218,
  title = {One-Year Real-World Outcomes of Intravitreal Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration in Japan: A Multicenter Retrospective Study},
  author = {Rikuto Mizuma and Yuki Mizuki and Akihiro Kamata and Junji Onishi and Takuto Sakono and Misa Suzuki and Nobuhisa Mizuki},
  year = {2026},
  journal = {Clinical Ophthalmology},
  doi = {10.2147/opth.s596218},
  url = {https://doi.org/10.2147/opth.s596218}
}

RIS

TY  - JOUR
TI  - One-Year Real-World Outcomes of Intravitreal Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration in Japan: A Multicenter Retrospective Study
AU  - Rikuto Mizuma
AU  - Yuki Mizuki
AU  - Akihiro Kamata
AU  - Junji Onishi
AU  - Takuto Sakono
AU  - Misa Suzuki
AU  - Nobuhisa Mizuki
PY  - 2026
JO  - Clinical Ophthalmology
DO  - 10.2147/opth.s596218
UR  - https://doi.org/10.2147/opth.s596218
ER  - 

APA

Mizuma, R., Mizuki, Y., Kamata, A., Onishi, J., Sakono, T., Suzuki, M., & Mizuki, N. (2026). One-Year Real-World Outcomes of Intravitreal Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration in Japan: A Multicenter Retrospective Study. Clinical Ophthalmology. https://doi.org/10.2147/opth.s596218

Source records